STOCK OPTION AGREEMENTStock Option Agreement • March 10th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research
WHEREAS the Company has established a Share Option Plan (such Share Option Plan, as may be supplemented or amended from time to time, is hereinafter called the “Plan”) for directors and full time employees of the Company or its subsidiaries and service providers of the Company or any entity controlled by the Company;
LICENSE AGREEMENTLicense Agreement • March 10th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research • New York
All ancillary compounds and materials associated with the development and characterization of ARRY-380 drug product and drug substance; including but not limited to:
